Synaptogenix (SNPX) Short Interest Ratio & Short Volume $2.12 -0.12 (-5.16%) Closing price 04/17/2025 03:50 PM EasternExtended Trading$2.10 -0.02 (-0.90%) As of 04/17/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Synaptogenix Short Interest DataSynaptogenix (SNPX) has a short interest of 12,000 shares, representing 0.88% of the float (the number of shares available for trading by the public). This marks a -37.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 26,469 shares to cover all short positions.Current Short Interest12,000 sharesPrevious Short Interest19,300 sharesChange Vs. Previous Month-37.82%Dollar Volume Sold Short$29,040.00Short Interest Ratio1.0 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares1,390,000 sharesFloat Size1,360,000 sharesShort Percent of Float0.88%Today's Trading Volume2,130 sharesAverage Trading Volume26,469 sharesToday's Volume Vs. Average8% Short Selling Synaptogenix? Sign up to receive the latest short interest report for Synaptogenix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNPX Short Interest Over TimeSNPX Days to Cover Over TimeSNPX Percentage of Float Shorted Over Time Synaptogenix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202512,000 shares $29,040.00 -37.8%0.9%1 $2.42 3/15/202519,300 shares $52,496.00 -11.5%1.5%1.3 $2.72 2/28/202521,800 shares $57,988.00 -26.9%1.6%1.5 $2.66 2/15/202529,800 shares $92,380.00 +17.3%2.2%1.7 $3.10 1/31/202525,400 shares $87,249.00 -2.7%1.9%1.3 $3.44 1/15/202526,100 shares $91,089.00 +31.8%2.0%1.3 $3.49 12/31/202419,800 shares $68,706.00 +725.0%1.5%0.8 $3.47 12/15/20242,400 shares $6,456.00 -66.7%0.2%0.1 $2.69 11/30/20247,200 shares $20,750.40 +30.9%0.5%0.3 $2.88 11/15/20245,500 shares $13,200.00 No Change0.4%0.2 $2.40 Get the Latest News and Ratings for SNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synaptogenix and its competitors with MarketBeat's FREE daily newsletter. 10/31/20245,500 shares $16,390.00 -68.8%0.4%0.2 $2.98 10/15/202417,600 shares $52,800.00 +120.0%1.4%0.6 $3.00 9/30/20248,000 shares $24,160.00 -29.2%0.6%0.3 $3.02 9/15/202411,300 shares $35,708.00 +130.6%0.9%0.3 $3.16 8/31/20244,900 shares $19,383.91 -53.3%0.4%0.1 $3.96 8/15/202410,500 shares $37,905.00 No Change0.8%0.3 $3.61 7/31/202410,500 shares $42,525.00 -27.1%0.9%0.3 $4.05 7/15/202414,400 shares $64,944.00 +100.0%1.2%0.3 $4.51 6/30/20247,200 shares $29,520.00 -7.7%0.6%0.1 $4.10 6/15/20247,800 shares $35,958.00 -63.2%0.6%0.1 $4.61 5/31/202421,200 shares $94,340.00 -18.5%1.8%0.4 $4.45 5/15/202426,000 shares $122,460.00 -13.9%2.2%0.5 $4.71 4/30/202430,200 shares $143,148.00 -10.4%2.9%0.6 $4.74 4/15/202433,700 shares $148,954.00 +183.2%3.2%0.7 $4.42 3/31/202411,900 shares $55,781.25 -97.2%1.1%0.3 $4.69 3/15/2024426,600 shares $86,173.20 -21.0%2.2%0.6 $0.20 2/29/2024540,300 shares $117,515.25 +12.7%2.7%0.7 $0.22 2/15/2024479,500 shares $85,782.55 +179.6%2.4%0.6 $0.18 1/31/2024171,500 shares $31,538.85 -48.3%0.9%0.3 $0.18 1/15/2024331,500 shares $86,521.50 -10.0%1.6%0.8 $0.26 12/31/2023368,300 shares $100,140.77 +46.9%1.8%0.9 $0.27 12/15/2023250,700 shares $68,641.66 -11.5%1.2%0.5 $0.27 11/30/2023283,200 shares $73,348.80 -47.6%1.4%0.4 $0.26 11/15/2023540,800 shares $123,789.12 -43.3%2.8%0.6 $0.23 10/31/2023953,200 shares $276,332.68 -33.3%9.8%1.1 $0.29 10/15/20231,430,000 shares $500,500.00 +2.1%14.7%1.7 $0.35 9/30/20231,400,000 shares $616,000.00 +380.3%14.3%1 $0.44 9/15/2023291,500 shares $91,822.50 -18.7%3.0%0.2 $0.32 8/31/2023358,600 shares $184,320.40 +40.5%3.7%0.4 $0.51 8/15/2023255,300 shares $167,017.26 -17.7%2.7%0.4 $0.65Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/31/2023310,100 shares $229,877.13 +11,385.2%4.5%0.5 $0.74 7/15/20232,700 shares $2,608.47 -37.2%0.0%0 $0.97 6/30/20234,300 shares $4,042.00 -51.7%0.1%0.1 $0.94 6/15/20238,900 shares $8,328.62 -75.6%0.1%0.2 $0.94 5/31/202336,400 shares $30,576.00 +1,482.6%0.6%0.7 $0.84 5/15/20232,300 shares $1,927.40 -94.1%0.0%0 $0.84 4/30/202339,000 shares $34,710.00 -87.6%0.6%0.7 $0.89 4/15/2023313,600 shares $269,664.64 +2.4%4.7%4.4 $0.86 3/31/2023306,300 shares $245,009.37 -1.5%4.6%4.1 $0.80 3/15/2023310,800 shares $268,096.08 +4.2%4.7%3 $0.86 2/28/2023298,400 shares $319,288.00 -22.5%4.6%1.7 $1.07 2/15/2023384,800 shares $469,456.00 +25.2%5.9%2.1 $1.22 1/31/2023307,400 shares $331,992.00 0.0%4.6%1.7 $1.08 1/15/2023307,500 shares $378,225.00 -39.9%4.6%1.8 $1.23 12/30/2022511,400 shares $593,224.00 +15.1%8.4%3.1 $1.16 12/15/2022444,500 shares $2.10 million +15.9%7.3%2.9 $4.73 11/30/2022383,600 shares $2.25 million +28.0%6.3%6.6 $5.86 11/15/2022299,800 shares $1.82 million +34.3%4.9%5.8 $6.07 10/31/2022223,200 shares $1.54 million -5.1%3.7%3.9 $6.90 10/15/2022235,200 shares $1.49 million -15.4%3.9%3.4 $6.32 9/30/2022278,100 shares $1.86 million +2.2%4.6%3.7 $6.70 9/15/2022272,000 shares $2.20 million -1.8%4.5%4.1 $8.09 8/31/2022277,000 shares $2.35 million +27.5%5.9%4.3 $8.48 8/15/2022217,300 shares $1.85 million -8.8%4.7%3.1 $8.52 7/31/2022238,300 shares $1.54 million +24.8%5.1%3.9 $6.48 7/15/2022190,900 shares $897,230.00 -23.6%4.1%3.6 $4.70 6/30/2022249,800 shares $1.30 million -7.3%5.4%5.4 $5.19 6/15/2022269,400 shares $1.40 million +11.8%5.8%5.5 $5.18 5/31/2022240,900 shares $1.56 million +9.0%5.2%4.7 $6.46 5/15/2022221,100 shares $1.03 million -31.3%4.8%4.1 $4.66 4/30/2022321,800 shares $1.71 million +10.4%7.0%4.7 $5.31 4/15/2022291,400 shares $2.05 million -20.7%6.3%2.1 $7.03 3/31/2022367,400 shares $2.84 million +2.7%8.0%2.6 $7.74 3/15/2022357,600 shares $2.26 million -7.1%7.9%2.5 $6.31 2/28/2022385,000 shares $2.71 million -19.7%8.5%2.6 $7.04 2/15/2022479,700 shares $3.42 million +26.2%10.6%3 $7.12 1/31/2022380,000 shares $2.96 million -40.3%8.8%2.4 $7.80 1/15/2022636,000 shares $5.70 million +8.2%14.8%7.1 $8.96 12/31/2021587,900 shares $5.00 million -9.7%N/A3.4 $8.51 12/15/2021651,000 shares $5.77 million -15.1%15.1%2.7 $8.87 11/30/2021766,900 shares $7.15 million +0.2%19.0%2.9 $9.32 11/15/2021765,700 shares $9.13 million -17.2%19.0%2.8 $11.92 10/29/2021924,500 shares $9.51 million -5.9%25.3%3.4 $10.29 10/15/2021981,900 shares $11.72 million +98.3%26.8%3.2 $11.94 9/30/2021495,200 shares $4.92 million +48.5%13.5%1.3 $9.94 9/15/2021333,500 shares $2.22 million -10.5%9.1%0.8 $6.65 8/31/2021372,400 shares $2.57 million -4.8%8.1%0.6 $6.90 8/13/2021391,100 shares $2.84 million No Change8.5%0.7 $7.27 SNPX Short Interest - Frequently Asked Questions What is Synaptogenix's current short interest? Short interest is the volume of Synaptogenix shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 12,000 shares of SNPX short. 0.88% of Synaptogenix's shares are currently sold short. Learn More on Synaptogenix's current short interest. What is a good short interest ratio for Synaptogenix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNPX shares currently have a short interest ratio of 1.0. Learn More on Synaptogenix's short interest ratio. What is a good short interest percentage for Synaptogenix? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.88% of Synaptogenix's floating shares are currently sold short. Is Synaptogenix's short interest increasing or decreasing? Synaptogenix saw a decline in short interest in March. As of March 31st, there was short interest totaling 12,000 shares, a decline of 37.8% from the previous total of 19,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Synaptogenix's float size? Synaptogenix currently has issued a total of 1,390,000 shares. Some of Synaptogenix's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Synaptogenix currently has a public float of 1,360,000 shares. How does Synaptogenix's short interest compare to its competitors? 0.88% of Synaptogenix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Synaptogenix: Marker Therapeutics, Inc. (5.35%), Synlogic, Inc. (0.72%), TherapeuticsMD, Inc. (1.49%), Moleculin Biotech, Inc. (4.08%), GeoVax Labs, Inc. (9.16%), ABVC BioPharma, Inc. (2.56%), Phio Pharmaceuticals Corp. (1.86%), Affimed (4.54%), Sensei Biotherapeutics, Inc. (11.56%), Minerva Neurosciences, Inc. (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Synaptogenix stock? Short selling SNPX is an investing strategy that aims to generate trading profit from Synaptogenix as its price is falling. SNPX shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Synaptogenix? A short squeeze for Synaptogenix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPX, which in turn drives the price of the stock up even further. How often is Synaptogenix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPX, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies MRKR Short Squeeze SYBX Short Squeeze TXMD Short Squeeze MBRX Short Squeeze GOVX Short Squeeze ABVC Short Squeeze PHIO Short Squeeze AFMD Short Squeeze SNSE Short Squeeze NERV Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNPX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.